Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  21,781 results for ""Cyclooxygenase 2 Inhibitors""

Your Filters

Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Screening bioactive compounds from Fangji Huangqi decoction for treating rheumatoid arthritis via COX-2 magnetic ligand fishing combined with in vivo validation.

  • Authors : Zhu Y; School of Traditional Chinese Medicine, Southern Medical University, Guangzhou, 510515, PR China; Guangdong Provincial Key Laboratory of Chinese Medicine Pharmaceutics, Southern Medical University, Guangzhou, 510515, PR China

Subjects: Drugs, Chinese Herbal*/Drugs, Chinese Herbal*/Drugs, Chinese Herbal*/pharmacology ; Drugs, Chinese Herbal*/Drugs, Chinese Herbal*/Drugs, Chinese Herbal*/chemistry ; Drugs, Chinese Herbal*/Drugs, Chinese Herbal*/Drugs, Chinese Herbal*/therapeutic use

  • Source: Journal of ethnopharmacology [J Ethnopharmacol] 2025 Jan 30; Vol. 337 (Pt 1), pp. 118725. Date of Electronic Publication: 2024 Aug 31.Publisher: Elsevier Sequoia Country of Publication: Ireland NLM ID: 7903310 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

COX-2 targeted therapy for diabetic foot ulcers using T7-enhanced CS-PVA membranes.

  • Authors : Murugan R; Department of Pharmacology, Saveetha Dental College and Hospitals, Saveetha Institute of Medical and Technical Sciences, Saveetha University, Chennai 600077, Tamil Nadu, India.; Ashok K

Subjects: Diabetic Foot*/Diabetic Foot*/Diabetic Foot*/drug therapy ; Diabetic Foot*/Diabetic Foot*/Diabetic Foot*/pathology ; Polyvinyl Alcohol*/Polyvinyl Alcohol*/Polyvinyl Alcohol*/chemistry

  • Source: International immunopharmacology [Int Immunopharmacol] 2024 Dec 25; Vol. 143 (Pt 1), pp. 113206. Date of Electronic Publication: 2024 Sep 30.Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 100965259 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

A Novel Platform Featuring Nanomagnetic Ligand Fishing Based on Fixed-Orientation Immobilized Magnetic Beads for Screening Potential Cyclooxygenase-2 Inhibitors from Panax notoginseng Leaves.

  • Authors : Zhang F; College of Chinese Materia Medica, Tianjin University of Traditional Chinese Medicine, 10 Poyanghu Road, West Area, Tuanbo New Town, Jinghai District, Tianjin 301617, China.; Sun F

Subjects: Plant Leaves*/Plant Leaves*/Plant Leaves*/chemistry ; Cyclooxygenase 2 Inhibitors*/Cyclooxygenase 2 Inhibitors*/Cyclooxygenase 2 Inhibitors*/chemistry ; Cyclooxygenase 2 Inhibitors*/Cyclooxygenase 2 Inhibitors*/Cyclooxygenase 2 Inhibitors*/pharmacology

  • Source: Molecules (Basel, Switzerland) [Molecules] 2024 Dec 09; Vol. 29 (23). Date of Electronic Publication: 2024 Dec 09.Publisher: MDPI Country of Publication: Switzerland NLM ID: 100964009 Publication Model: Electronic Cited Medium: Internet ISSN: 1420-3049

Record details

Read More Add to Saved list
×
Academic Journal

1,5- diaryl pyrazole-loaded chitosan nanoparticles as COX-2 inhibitors, mitigate neoplastic growth by regulating NF-κB pathway in-vivo zebrafish model.

  • Authors : Murugan R; Department of Pharmacology, Saveetha Dental College, Saveetha Institute of Medical and Technical Sciences (SIMATS), Chennai 600077, Tamil Nadu, India.; Selvam M

Subjects: Zebrafish* ; Pyrazoles*/Pyrazoles*/Pyrazoles*/chemistry ; Pyrazoles*/Pyrazoles*/Pyrazoles*/pharmacology

  • Source: International journal of biological macromolecules [Int J Biol Macromol] 2024 Dec; Vol. 283 (Pt 1), pp. 137599. Date of Electronic Publication: 2024 Nov 13.Publisher: Elsevier Country of Publication: Netherlands NLM ID: 7909578 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Indole-based COX-2 inhibitors: A decade of advances in inflammation, cancer, and Alzheimer's therapy.

  • Authors : Shah M; Parul Institute of Pharmacy, Parul University, Vadodara, Gujarat, India.; Parmar R

Subjects: Indoles*/Indoles*/Indoles*/chemistry ; Indoles*/Indoles*/Indoles*/pharmacology ; Indoles*/Indoles*/Indoles*/therapeutic use

  • Source: Bioorganic chemistry [Bioorg Chem] 2024 Dec; Vol. 153, pp. 107931. Date of Electronic Publication: 2024 Oct 29.Publisher: Elsevier Country of Publication: United States NLM ID: 1303703 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Computational exploration of novel ketoprofen derivatives: Molecular dynamics simulations and MM-PBSA calculations for COX-2 inhibition as promising anti-inflammatory drugs.

  • Authors : Bettadj FZY; Laboratory of Applied Thermodynamics and Molecular Modelling, Department of Chemistry, Faculty of Science, University of Tlemcen, BP 119, 13000, Tlemcen, Algeria.; Benchouk W

Subjects: Ketoprofen*/Ketoprofen*/Ketoprofen*/chemistry ; Cyclooxygenase 2*/Cyclooxygenase 2*/Cyclooxygenase 2*/metabolism ; Cyclooxygenase 2*/Cyclooxygenase 2*/Cyclooxygenase 2*/chemistry

  • Source: Computers in biology and medicine [Comput Biol Med] 2024 Dec; Vol. 183, pp. 109203. Date of Electronic Publication: 2024 Oct 11.Publisher: Elsevier Country of Publication: United States NLM ID: 1250250 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Discovery of metabolite from the insect-derived endophytic Penicillium chrysogenum and their COX-2 inhibitory activity.

  • Authors : Zhu CY; Institue for Inheritance-Based Innovation of Chinese Medicine, Guangdong Provincial Key Laboratory of Chinese Medicine Ingredients and Gut Microbiomics, School of Pharmacy, Shenzhen University Medical School, Shenzhen 518060, PR China.; Luo Q

Subjects: Penicillium chrysogenum* ; Cyclooxygenase 2 Inhibitors*/Cyclooxygenase 2 Inhibitors*/Cyclooxygenase 2 Inhibitors*/isolation & purification ; Cyclooxygenase 2 Inhibitors*/Cyclooxygenase 2 Inhibitors*/Cyclooxygenase 2 Inhibitors*/pharmacology

  • Source: Fitoterapia [Fitoterapia] 2024 Dec; Vol. 179, pp. 106238. Date of Electronic Publication: 2024 Sep 24.Publisher: Elsevier Country of Publication: Netherlands NLM ID: 16930290R Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

The role of traditional NSAIDs and selective COX-2 inhibitors on COVID-19 outcomes: a real-world data study.

Subjects: Anti-Inflammatory Agents, Non-Steroidal*/Anti-Inflammatory Agents, Non-Steroidal*/Anti-Inflammatory Agents, Non-Steroidal*/therapeutic use ; Anti-Inflammatory Agents, Non-Steroidal*/Anti-Inflammatory Agents, Non-Steroidal*/Anti-Inflammatory Agents, Non-Steroidal*/adverse effects ; Cyclooxygenase 2 Inhibitors*/Cyclooxygenase 2 Inhibitors*/Cyclooxygenase 2 Inhibitors*/therapeutic use

  • Source: Inflammopharmacology [Inflammopharmacology] 2024 Dec; Vol. 32 (6), pp. 3697-3705. Date of Electronic Publication: 2024 Sep 23.Publisher: Birkhäuser Country of Publication: Switzerland NLM ID: 9112626 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Integration of STING activation and COX-2 inhibition via steric-hindrance effect tuned nanoreactors for cancer chemoimmunotherapy.

  • Authors : Zhang P; Department of Urology, the Affiliated Hospital of Qingdao University, Qingdao 266003, China.; Zhong D

Subjects: Immunotherapy*/Immunotherapy*/Immunotherapy*/methods ; Cyclooxygenase 2*/Cyclooxygenase 2*/Cyclooxygenase 2*/metabolism ; Metal-Organic Frameworks*/Metal-Organic Frameworks*/Metal-Organic Frameworks*/chemistry

  • Source: Biomaterials [Biomaterials] 2024 Dec; Vol. 311, pp. 122695. Date of Electronic Publication: 2024 Jun 29.Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 8100316 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Comparison of a fixed-dose combination of Celecoxib/PG201 [Layla®] versus co-administration of individual formulations in healthy participants: A randomized trial.

  • Authors : Song JH; Clinical Trials Center, Chungnam National University Hospital, Daejeon, Republic of Korea.; Department of Medical Science, Chungnam National University College of Medicine, Daejeon, Republic of Korea.

Subjects: Celecoxib*/Celecoxib*/Celecoxib*/administration & dosage ; Celecoxib*/Celecoxib*/Celecoxib*/pharmacokinetics ; Celecoxib*/Celecoxib*/Celecoxib*/adverse effects

  • Source: Medicine [Medicine (Baltimore)] 2024 Nov 15; Vol. 103 (46), pp. e40494.Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 2985248R Publication Model: Print Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
  • 1-10 of  21,781 results for ""Cyclooxygenase 2 Inhibitors""